CalciMedica, Inc. (CALC)
2.17
-0.03
(-1.36%)
USD |
NASDAQ |
Sep 04, 16:00
2.23
+0.06
(+2.76%)
After-Hours: 20:00
CalciMedica Debt to Equity Ratio : 1.669 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.669 |
| March 31, 2026 | -6.069 |
| December 31, 2025 | -1.461 |
| September 30, 2025 | -33.21 |
| June 30, 2025 | 1.393 |
| March 31, 2025 | 0.7899 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.9428 |
| September 30, 2022 | 0.0073 |
| June 30, 2022 | 0.008 |
| March 31, 2022 | 0.0087 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -1.276 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 19.50M |
| Total Liabilities (Quarterly) | 13.99M |
| Shareholders Equity (Quarterly) | 5.513M |
| Current Ratio | 5.577 |
| Net Debt Paydown Yield | -0.38% |